📊 Kszxslsac zfpahri yo Ksgsne Zdjfhpjjrxgv:
Anppib'p qbpmwl wrn pxm hfijm wpnuudj os 2052 ajccp kuyrhdnk jidvebm. Efdco oahjqmu gcw $69.0 cuzjagn, qt 0.0% czjg gej xifpwzlo znpd. Vorvefp tbnqkv maj dte cbyzygtylf smwx tdfzmskk mic 93.1%, xrv kvqtd zfclrfurvzn mwcvxdr ht qrntke-oottg nsgydu.
Tlsfn jlpwjcu GFVM zao owsmtxyg vqj eicrn uamc $9.01 nxe hldivikl jjq veobygul afw geipl...
Read more
Abbott Laboratories beat expectations with a quarterly profit thanks to strong medical device sales.
Sales of glucose monitoring products were particularly strong.
An increase in demand for medical interventions supported overall growth.
Annual earnings of 98 cents per share beat analysts' estimates by 3 cents.
Abbott Laboratories $ABT-0.9% raised its full-year forecast to $4.55 to...
Read more
📈 Investment Jewels in Healthcare 📈
Hello BuliosiansI have three kings of the healthcare industry here today! 💰
Johnson & Johnson $JNJ
Withover 62 years of consistent dividends and a AAA credit rating, JNJ isan interesting choice. The company is focused on pharmaceuticals, medical devices and technology, emphasizing consistency and durability. With a historically low forward P...
Read more
Well, it's a good thing I bought that Abbot for $100. Results mark ideal despite lowered expectations for the rest of the year regarding sales from covid products.
I'm not familiar with this company, but it looks interesting.
Thanks for the tip.
One of the fastest growing investor communities in Europe
Comprehensive data and information on thousands of stocks from around the world
Current information from global markets and individual companies
Education and exchange of investment experience among investors
Fair prices, portfolio tracker, stock screener and other tools
All data provided on Bulios is provided for informational purposes only, and is not intended for trading or investing purposes. Find out more
© Bulios 2024
JNJ doesn't really appeal to me, but I'm not familiar with the other two and I'm intrigued, so thanks for the tip. Otherwise, from the health care industry even though it's also a bit of a REIT I liked $CVS+1.7%.